Announcement on the Progress of Litigation Involving the Company
Zhejiang Wofoo Biological Technology Co., Ltd. (hereinafter referred to as "the Company") and all members of the Board of Directors guarantee that the content of this information disclosure is true, accurate, and complete, with no false records, misleading statements, or significant omissions.
Important Content Reminder:
- Current stage of the case: Second-instance judgment has been rendered.
- Position of the listed company: Appellant (original plaintiff in the first instance).
- Amount involved: 10,961,305.35 yuan plus interest.
- Impact on the listed company's profits and losses: The second-instance judgment is final. As of the date of this announcement, the specific impact on the company's current and future profits or owner’s equity will depend on the actual execution of the judgment.
Basic Information on the Litigation
Zhejiang Wofoo Biological Technology Co., Ltd. filed a lawsuit against Shanghai Lihe Equity Investment Partnership (Limited Partnership) for breaching commitments regarding the reduction of the company's stock. The company received a notice from the People's Court of Pudong New District, Shanghai (hereinafter referred to as "the first-instance court") on July 5, 2024, regarding the mediation case number (2024) Hu 0115 Min Su Qian 66428. For details, please refer to the announcement disclosed by the company on July 8, 2024, on the Shenzhen Stock Exchange website and in media meeting the requirements of the China Securities Regulatory Commission (Announcement No.: 2024-017).